AIxCrypto Holdings, Inc. (AIXC) Stock Analysis & Investment Frameworks
AIxCrypto Holdings, Inc. (AIXC) stock analysis on Invetso. Review AIxCrypto Holdings, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
AIxCrypto Holdings, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Technology
- Industry: Software - Infrastructure
- Country: US
AIxCrypto Holdings, Inc. Key Financial Metrics
- Market Cap: $27.72M
- Revenue: $N/A
- ROE: -97.40%
- ROIC: -281.17%
- Dividend Yield: N/A
About AIxCrypto Holdings, Inc.
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
AIxCrypto Holdings, Inc. Investment Frameworks
Invetso analyzes AIxCrypto Holdings, Inc. (AIXC) across the following frameworks:
- AIxCrypto Holdings, Inc. 10Y Growth Potential
- AIxCrypto Holdings, Inc. Scenario Analysis
- AIxCrypto Holdings, Inc. Risks & Opportunities
- AIxCrypto Holdings, Inc. Economic Moat
- AIxCrypto Holdings, Inc. Business Model
- AIxCrypto Holdings, Inc. Management
- AIxCrypto Holdings, Inc. SWOT Analysis
- AIxCrypto Holdings, Inc. Porter's 5 Forces
- AIxCrypto Holdings, Inc. PESTLE Analysis
- AIxCrypto Holdings, Inc. ESG Analysis